I wish to perform transwell migration assay for checking the effect of a drug on the migratory properties of Triple Negative Breast Cancer cell line (MDA MB 231). Would a difference in FBS concentration in the upper and lower chambers of the inserts act as sufficient cue to promote cell migration?